FDA MAP
  • Home
  • Training
    • WORKSHOPS
    • WEBINARS
    • CUSTOM TRAINING
  • SERVICES
    • REGULATORY SERVICES
    • FDA AUDITING
    • QUALITY ASSURANCE
    • CLINICAL TRIAL SERVICES
  • News Releases
  • About Us
Webinars >>Clinical Trial
Safety Reporting in Clinical Trials: Are you Compliant with the Current FDA Rules?
​

Timely and adequate reporting of adverse events to FDA is the primary responsibility of the sponsors of INDs. FDA rules define the agency’s current expectations of sponsors, investigators, IRBs, and other personnel responsible for reporting safety related information while conducting clinical trials with a new investigational product or a generic drug. Also, the bioavailability and bioequivalence (BA/BE) studies (studies done for generic drugs) are subject to these IND safety reporting rules. The rules also require a safety database and trends data on adverse events to be submitted at least annually. There are stricter requirements for sponsors and investigators for evaluating a given adverse event before reporting it to the FDA and/or the IRB. Several definitions in the regulations have been revised recently and rules have been harmonized with internationally acceptable practices for safety reporting in clinical trials. The new requirements were inserted into the regulations to allow FDA the authority to enforce the same. Sponsor, investigators and all relevant personnel are supposed to be compliant with these rules or face penalties for non-compliance.
Why should you attend:
​

If your company or organization is involved in clinical trials, if you are a clinical site or safety monitoring/pharmacovigilance organization, if you are with an IRB overseeing clinical trials, or if you are not sure of your compliance status with the current regulations, you can get valuable tips and training in less than an hour. This seminar will discuss the current requirements, differences from the older requirements, and tips to not only to be compliant but processes to document how you address safety events in your clinical trials.
Areas Covered in the Session:
  • Current regulatory requirements.
  • Grades of adverse events and metered reporting requirements
  • Role of clinical investigators and sponsors.
  • What SOPs are needed for adverse event reporting
  • Training requirements for personnel
  • Good documentation practices for safety monitoring
Who will benefit:
  • Safety reporting professionals
  • QA/QC/Compliance/Regulatory affairs professionals
  • Clinical trial professionals (e.g., CRAs, coordinators, nurses, pharmacists)
  • Investigators participating in clinical trials
  • Sponsors and investigator-sponsors of clinical trials
  • Pharmacovigilance professionals
  • Clinical trial specialists
  • Project Managers
  • People investing in FDA-regulated product development projects
Date: October 6, 2022
​Duration: 60 Minutes
​
Time: 12 PM EST
Register Online

Speaker: Mukesh Kumar
​
PhD, RAC | Brij Strategic Consultations, 
 USA
​

Picture

    For more info, fill the box below. We will contact you within 24 hrs.

Submit
For additional information on the workshop agenda and logistics, please call 410-501-5777 or email: info@fdamap.com

Our Services

  • Workshops
  • Webinars
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions
  • Corporate Registration
  • Certification Program
  • Smart Recruitment
  • Corporate Registration - Online Workshop​

Company

  • About Us​
  • Testimonials
  • Free Resources
  • Newsletter
  • Videos (Free Tutorials)

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy
  • News Archive
Consultation Service
FDA Training Company
Copyright © 2022 FDAMap.com
Use of this Web site constitutes acceptance of the FDAMap Terms of Use and Privacy Policy.